NDC Package 33261-870-30 Terazosin

View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

33261-870-30

Package Description:

30 CAPSULE in 1 BOTTLE, PLASTIC

Product Code:

33261-870

Proprietary Name:

Terazosin

Usage Information:

Terazosin Capsules, USP are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with Terazosin Capsules, USP. The long-term effects of Terazosin Capsules, USP on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin Capsules, USP are also indicated for the treatment of hypertension. It can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.

11-Digit NDC Billing Format:

33261087030

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

30 EA

NDC to RxNorm Crosswalk:

RxCUI: 260376 - terazosin HCl 10 MG Oral Capsule

RxCUI: 260376 - terazosin 10 MG Oral Capsule

RxCUI: 260376 - terazosin (as terazosin HCl) 10 MG Oral Capsule

RxCUI: 313215 - terazosin HCl 1 MG Oral Capsule

RxCUI: 313215 - terazosin 1 MG Oral Capsule

Labeler Name:

Aidarex Pharmaceuticals Llc

Sample Package:

Start Marketing Date:

04-12-2001

Listing Expiration Date:

12-31-2019

Exclude Flag:

Code Structure:

33261 - Aidarex Pharmaceuticals Llc
- 33261-870 - Terazosin
  - 33261-870-30 - 30 CAPSULE in 1 BOTTLE, PLASTIC

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 33261-870-30?

The NDC Packaged Code 33261-870-30 is assigned to a package of 30 capsule in 1 bottle, plastic of Terazosin, labeled by Aidarex Pharmaceuticals Llc. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package.

Is NDC 33261-870 included in the NDC Directory?

No, Terazosin with product code 33261-870 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Aidarex Pharmaceuticals Llc on April 12, 2001 and its listing in the NDC Directory is set to expire on December 31, 2019 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 33261-870-30?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

What is the 11-digit format for NDC 33261-870-30?

The 11-digit format is 33261087030. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	33261-870-30	5-4-2	33261-0870-30

Table of Contents